This season, close to 2 million doses of influenza vaccine have been purchased by the HSE, which is nearly double the amount administered last season.
The HSE has procured 1.4 million doses of Quadrivalent Influenza Vaccine (QIV) for adults and children, which is over 20% more influenza than was used last season, as increased uptake was expected in the targeted groups.
The HSE has also purchased 600,000 doses of Live Attenuated Influenza Vaccine (LAIV) for children aged 2-12 years old.
By the 28th October a total of 950,000 QIV influenza vaccines will have been delivered around the country, an increase of 10% compared to the same time last season.
There has been unprecedented demand for influenza vaccine this season, which is a positive reflection of public awareness. In order to ensure we maximise the benefit of the remaining stock we need to ensure the most vulnerable are prioritised for vaccination.
In accordance with World Health Organization recommendations for prioritisation of influenza vaccine during COVID-19, the highest priority risk groups for vaccination are people aged 65 years and older and healthcare and home care workers with direct patient contact.
For more information visit www.hse.ie/flu
This page was updated on 27 October 2020